Medartis Holding AG (MED.SW) stock: key figures, P/E, revenue and dividend

Health Care · Switzerland · ISIN CH0386200239

Price
97.30 CHF
Market cap
1.21 bn CHF
P/E (2025)
144.97
P/S (2025)
4.50
Dividend yield
0.00 %
Net margin
2.97 %
Return on equity (ROE)
2.90 %
Return on assets (ROA)
1.43 %

Medartis Holding AG financials

Fiscal year20242025
Revenue224.00 m CHF269.00 m CHF
Gross profit178.00 m CHF204.00 m CHF
EBIT7.00 m CHF1.00 m CHF
Net income3.53 m CHF8.00 m CHF
Diluted EPS – continuing operations0.28 CHF0.67 CHF

Full history since 2014, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Medartis Holding AG

Medartis Holding AG, a medical device company, engages in the development, manufacturing, and sales of implant solutions worldwide. The company's medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. It provides products for the hand, wrist, forearm, elbow, shoulder, and foot and ankle, as well as for upper and lower extremities, mandible, midface, orthognathic under the APTUS and MODUS names, as well as CMX services through web portal, and kerimedical products. The company was incorporated in 1997 and is headquartered in Basel, Switzerland.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.